Global Opioid Antagonist Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Page: 109

Published Date: 18 Jan 2022

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Opioid Antagonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Opioid Antagonist market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Hospitals accounting for % of the Opioid Antagonist global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Opioid Antagonist include Indivior, Alkermes, Titan Pharmaceuticals, Opiant Pharmaceuticals, and Hikma Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Opioid Antagonist market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Oral
    Parenteral

Market segment by Application can be divided into
    Hospitals
    Clinics
    Others

The key market players for global Opioid Antagonist market are listed below:
    Indivior
    Alkermes
    Titan Pharmaceuticals
    Opiant Pharmaceuticals
    Hikma Pharmaceuticals
    Orexo
    Camurus
    Acura Pharmaceuticals
    Shionogi
    BioDelivery Sciences International
    Collegium Pharmaceutical
    AstraZeneca

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioid Antagonist product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioid Antagonist, with price, sales, revenue and global market share of Opioid Antagonist from 2019 to 2022.
Chapter 3, the Opioid Antagonist competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Antagonist breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Opioid Antagonist market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Opioid Antagonist.
Chapter 13, 14, and 15, to describe Opioid Antagonist sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Opioid Antagonist Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Opioid Antagonist Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Oral
        1.2.3 Parenteral
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Opioid Antagonist Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Opioid Antagonist Market Size & Forecast
        1.4.1 Global Opioid Antagonist Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Opioid Antagonist Sales in Volume (2017-2028)
        1.4.3 Global Opioid Antagonist Price (2017-2028)
    1.5 Global Opioid Antagonist Production Capacity Analysis
        1.5.1 Global Opioid Antagonist Total Production Capacity (2017-2028)
        1.5.2 Global Opioid Antagonist Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Opioid Antagonist Market Drivers
        1.6.2 Opioid Antagonist Market Restraints
        1.6.3 Opioid Antagonist Trends Analysis

2 Manufacturers Profiles
    2.1 Indivior
        2.1.1 Indivior Details
        2.1.2 Indivior Major Business
        2.1.3 Indivior Opioid Antagonist Product and Services
        2.1.4 Indivior Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Alkermes
        2.2.1 Alkermes Details
        2.2.2 Alkermes Major Business
        2.2.3 Alkermes Opioid Antagonist Product and Services
        2.2.4 Alkermes Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Titan Pharmaceuticals
        2.3.1 Titan Pharmaceuticals Details
        2.3.2 Titan Pharmaceuticals Major Business
        2.3.3 Titan Pharmaceuticals Opioid Antagonist Product and Services
        2.3.4 Titan Pharmaceuticals Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Opiant Pharmaceuticals
        2.4.1 Opiant Pharmaceuticals Details
        2.4.2 Opiant Pharmaceuticals Major Business
        2.4.3 Opiant Pharmaceuticals Opioid Antagonist Product and Services
        2.4.4 Opiant Pharmaceuticals Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Hikma Pharmaceuticals
        2.5.1 Hikma Pharmaceuticals Details
        2.5.2 Hikma Pharmaceuticals Major Business
        2.5.3 Hikma Pharmaceuticals Opioid Antagonist Product and Services
        2.5.4 Hikma Pharmaceuticals Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Orexo
        2.6.1 Orexo Details
        2.6.2 Orexo Major Business
        2.6.3 Orexo Opioid Antagonist Product and Services
        2.6.4 Orexo Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Camurus
        2.7.1 Camurus Details
        2.7.2 Camurus Major Business
        2.7.3 Camurus Opioid Antagonist Product and Services
        2.7.4 Camurus Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Acura Pharmaceuticals
        2.8.1 Acura Pharmaceuticals Details
        2.8.2 Acura Pharmaceuticals Major Business
        2.8.3 Acura Pharmaceuticals Opioid Antagonist Product and Services
        2.8.4 Acura Pharmaceuticals Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Shionogi
        2.9.1 Shionogi Details
        2.9.2 Shionogi Major Business
        2.9.3 Shionogi Opioid Antagonist Product and Services
        2.9.4 Shionogi Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 BioDelivery Sciences International
        2.10.1 BioDelivery Sciences International Details
        2.10.2 BioDelivery Sciences International Major Business
        2.10.3 BioDelivery Sciences International Opioid Antagonist Product and Services
        2.10.4 BioDelivery Sciences International Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Collegium Pharmaceutical
        2.11.1 Collegium Pharmaceutical Details
        2.11.2 Collegium Pharmaceutical Major Business
        2.11.3 Collegium Pharmaceutical Opioid Antagonist Product and Services
        2.11.4 Collegium Pharmaceutical Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 AstraZeneca
        2.12.1 AstraZeneca Details
        2.12.2 AstraZeneca Major Business
        2.12.3 AstraZeneca Opioid Antagonist Product and Services
        2.12.4 AstraZeneca Opioid Antagonist Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Opioid Antagonist Breakdown Data by Manufacturer
    3.1 Global Opioid Antagonist Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Opioid Antagonist Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Opioid Antagonist
    3.4 Market Concentration Rate
        3.4.1 Top 3 Opioid Antagonist Manufacturer Market Share in 2021
        3.4.2 Top 6 Opioid Antagonist Manufacturer Market Share in 2021
    3.5 Global Opioid Antagonist Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Opioid Antagonist Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Opioid Antagonist Market Size by Region
        4.1.1 Global Opioid Antagonist Sales in Volume by Region (2017-2028)
        4.1.2 Global Opioid Antagonist Revenue by Region (2017-2028)
    4.2 North America Opioid Antagonist Revenue (2017-2028)
    4.3 Europe Opioid Antagonist Revenue (2017-2028)
    4.4 Asia-Pacific Opioid Antagonist Revenue (2017-2028)
    4.5 South America Opioid Antagonist Revenue (2017-2028)
    4.6 Middle East and Africa Opioid Antagonist Revenue (2017-2028)

5 Market Segment by Type
    5.1 Global Opioid Antagonist Sales in Volume by Type (2017-2028)
    5.2 Global Opioid Antagonist Revenue by Type (2017-2028)
    5.3 Global Opioid Antagonist Price by Type (2017-2028)

6 Market Segment by Application
    6.1 Global Opioid Antagonist Sales in Volume by Application (2017-2028)
    6.2 Global Opioid Antagonist Revenue by Application (2017-2028)
    6.3 Global Opioid Antagonist Price by Application (2017-2028)

7 North America by Country, by Type, and by Application
    7.1 North America Opioid Antagonist Sales by Type (2017-2028)
    7.2 North America Opioid Antagonist Sales by Application (2017-2028)
    7.3 North America Opioid Antagonist Market Size by Country
        7.3.1 North America Opioid Antagonist Sales in Volume by Country (2017-2028)
        7.3.2 North America Opioid Antagonist Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application
    8.1 Europe Opioid Antagonist Sales by Type (2017-2028)
    8.2 Europe Opioid Antagonist Sales by Application (2017-2028)
    8.3 Europe Opioid Antagonist Market Size by Country
        8.3.1 Europe Opioid Antagonist Sales in Volume by Country (2017-2028)
        8.3.2 Europe Opioid Antagonist Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Opioid Antagonist Sales by Type (2017-2028)
    9.2 Asia-Pacific Opioid Antagonist Sales by Application (2017-2028)
    9.3 Asia-Pacific Opioid Antagonist Market Size by Region
        9.3.1 Asia-Pacific Opioid Antagonist Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Opioid Antagonist Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application
    10.1 South America Opioid Antagonist Sales by Type (2017-2028)
    10.2 South America Opioid Antagonist Sales by Application (2017-2028)
    10.3 South America Opioid Antagonist Market Size by Country
        10.3.1 South America Opioid Antagonist Sales in Volume by Country (2017-2028)
        10.3.2 South America Opioid Antagonist Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Opioid Antagonist Sales by Type (2017-2028)
    11.2 Middle East & Africa Opioid Antagonist Sales by Application (2017-2028)
    11.3 Middle East & Africa Opioid Antagonist Market Size by Country
        11.3.1 Middle East & Africa Opioid Antagonist Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Opioid Antagonist Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain
    12.1 Raw Material of Opioid Antagonist and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Opioid Antagonist
    12.3 Opioid Antagonist Production Process
    12.4 Opioid Antagonist Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Opioid Antagonist Typical Distributors
    13.3 Opioid Antagonist Typical Customers

14 Research Findings and Conclusion

15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Opioid Antagonist Revenue by Type, (USD Million), 2017 & 2021 & 2028
    Table 2. Global Opioid Antagonist Revenue by Application, (USD Million), 2017 & 2021 & 2028
    Table 3. Indivior Basic Information, Manufacturing Base and Competitors
    Table 4. Indivior Major Business
    Table 5. Indivior Opioid Antagonist Product and Services
    Table 6. Indivior Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 7. Alkermes Basic Information, Manufacturing Base and Competitors
    Table 8. Alkermes Major Business
    Table 9. Alkermes Opioid Antagonist Product and Services
    Table 10. Alkermes Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 11. Titan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 12. Titan Pharmaceuticals Major Business
    Table 13. Titan Pharmaceuticals Opioid Antagonist Product and Services
    Table 14. Titan Pharmaceuticals Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 15. Opiant Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 16. Opiant Pharmaceuticals Major Business
    Table 17. Opiant Pharmaceuticals Opioid Antagonist Product and Services
    Table 18. Opiant Pharmaceuticals Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 19. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 20. Hikma Pharmaceuticals Major Business
    Table 21. Hikma Pharmaceuticals Opioid Antagonist Product and Services
    Table 22. Hikma Pharmaceuticals Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 23. Orexo Basic Information, Manufacturing Base and Competitors
    Table 24. Orexo Major Business
    Table 25. Orexo Opioid Antagonist Product and Services
    Table 26. Orexo Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 27. Camurus Basic Information, Manufacturing Base and Competitors
    Table 28. Camurus Major Business
    Table 29. Camurus Opioid Antagonist Product and Services
    Table 30. Camurus Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 31. Acura Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 32. Acura Pharmaceuticals Major Business
    Table 33. Acura Pharmaceuticals Opioid Antagonist Product and Services
    Table 34. Acura Pharmaceuticals Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 35. Shionogi Basic Information, Manufacturing Base and Competitors
    Table 36. Shionogi Major Business
    Table 37. Shionogi Opioid Antagonist Product and Services
    Table 38. Shionogi Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 39. BioDelivery Sciences International Basic Information, Manufacturing Base and Competitors
    Table 40. BioDelivery Sciences International Major Business
    Table 41. BioDelivery Sciences International Opioid Antagonist Product and Services
    Table 42. BioDelivery Sciences International Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 43. Collegium Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 44. Collegium Pharmaceutical Major Business
    Table 45. Collegium Pharmaceutical Opioid Antagonist Product and Services
    Table 46. Collegium Pharmaceutical Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 47. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 48. AstraZeneca Major Business
    Table 49. AstraZeneca Opioid Antagonist Product and Services
    Table 50. AstraZeneca Opioid Antagonist Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 51. Global Opioid Antagonist Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
    Table 52. Global Opioid Antagonist Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
    Table 53. Market Position of Manufacturers in Opioid Antagonist, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
    Table 54. Global Opioid Antagonist Production Capacity by Company, (K Units): 2020 VS 2021
    Table 55. Head Office and Opioid Antagonist Production Site of Key Manufacturer
    Table 56. Opioid Antagonist New Entrant and Capacity Expansion Plans
    Table 57. Opioid Antagonist Mergers & Acquisitions in the Past Five Years
    Table 58. Global Opioid Antagonist Sales by Region (2017-2022) & (K Units)
    Table 59. Global Opioid Antagonist Sales by Region (2023-2028) & (K Units)
    Table 60. Global Opioid Antagonist Revenue by Region (2017-2022) & (USD Million)
    Table 61. Global Opioid Antagonist Revenue by Region (2023-2028) & (USD Million)
    Table 62. Global Opioid Antagonist Sales by Type (2017-2022) & (K Units)
    Table 63. Global Opioid Antagonist Sales by Type (2023-2028) & (K Units)
    Table 64. Global Opioid Antagonist Revenue by Type (2017-2022) & (USD Million)
    Table 65. Global Opioid Antagonist Revenue by Type (2023-2028) & (USD Million)
    Table 66. Global Opioid Antagonist Price by Type (2017-2022) & (US$/Unit)
    Table 67. Global Opioid Antagonist Price by Type (2023-2028) & (US$/Unit)
    Table 68. Global Opioid Antagonist Sales by Application (2017-2022) & (K Units)
    Table 69. Global Opioid Antagonist Sales by Application (2023-2028) & (K Units)
    Table 70. Global Opioid Antagonist Revenue by Application (2017-2022) & (USD Million)
    Table 71. Global Opioid Antagonist Revenue by Application (2023-2028) & (USD Million)
    Table 72. Global Opioid Antagonist Price by Application (2017-2022) & (US$/Unit)
    Table 73. Global Opioid Antagonist Price by Application (2023-2028) & (US$/Unit)
    Table 74. North America Opioid Antagonist Sales by Country (2017-2022) & (K Units)
    Table 75. North America Opioid Antagonist Sales by Country (2023-2028) & (K Units)
    Table 76. North America Opioid Antagonist Revenue by Country (2017-2022) & (USD Million)
    Table 77. North America Opioid Antagonist Revenue by Country (2023-2028) & (USD Million)
    Table 78. North America Opioid Antagonist Sales by Type (2017-2022) & (K Units)
    Table 79. North America Opioid Antagonist Sales by Type (2023-2028) & (K Units)
    Table 80. North America Opioid Antagonist Sales by Application (2017-2022) & (K Units)
    Table 81. North America Opioid Antagonist Sales by Application (2023-2028) & (K Units)
    Table 82. Europe Opioid Antagonist Sales by Country (2017-2022) & (K Units)
    Table 83. Europe Opioid Antagonist Sales by Country (2023-2028) & (K Units)
    Table 84. Europe Opioid Antagonist Revenue by Country (2017-2022) & (USD Million)
    Table 85. Europe Opioid Antagonist Revenue by Country (2023-2028) & (USD Million)
    Table 86. Europe Opioid Antagonist Sales by Type (2017-2022) & (K Units)
    Table 87. Europe Opioid Antagonist Sales by Type (2023-2028) & (K Units)
    Table 88. Europe Opioid Antagonist Sales by Application (2017-2022) & (K Units)
    Table 89. Europe Opioid Antagonist Sales by Application (2023-2028) & (K Units)
    Table 90. Asia-Pacific Opioid Antagonist Sales by Region (2017-2022) & (K Units)
    Table 91. Asia-Pacific Opioid Antagonist Sales by Region (2023-2028) & (K Units)
    Table 92. Asia-Pacific Opioid Antagonist Revenue by Region (2017-2022) & (USD Million)
    Table 93. Asia-Pacific Opioid Antagonist Revenue by Region (2023-2028) & (USD Million)
    Table 94. Asia-Pacific Opioid Antagonist Sales by Type (2017-2022) & (K Units)
    Table 95. Asia-Pacific Opioid Antagonist Sales by Type (2023-2028) & (K Units)
    Table 96. Asia-Pacific Opioid Antagonist Sales by Application (2017-2022) & (K Units)
    Table 97. Asia-Pacific Opioid Antagonist Sales by Application (2023-2028) & (K Units)
    Table 98. South America Opioid Antagonist Sales by Country (2017-2022) & (K Units)
    Table 99. South America Opioid Antagonist Sales by Country (2023-2028) & (K Units)
    Table 100. South America Opioid Antagonist Revenue by Country (2017-2022) & (USD Million)
    Table 101. South America Opioid Antagonist Revenue by Country (2023-2028) & (USD Million)
    Table 102. South America Opioid Antagonist Sales by Type (2017-2022) & (K Units)
    Table 103. South America Opioid Antagonist Sales by Type (2023-2028) & (K Units)
    Table 104. South America Opioid Antagonist Sales by Application (2017-2022) & (K Units)
    Table 105. South America Opioid Antagonist Sales by Application (2023-2028) & (K Units)
    Table 106. Middle East & Africa Opioid Antagonist Sales by Region (2017-2022) & (K Units)
    Table 107. Middle East & Africa Opioid Antagonist Sales by Region (2023-2028) & (K Units)
    Table 108. Middle East & Africa Opioid Antagonist Revenue by Region (2017-2022) & (USD Million)
    Table 109. Middle East & Africa Opioid Antagonist Revenue by Region (2023-2028) & (USD Million)
    Table 110. Middle East & Africa Opioid Antagonist Sales by Type (2017-2022) & (K Units)
    Table 111. Middle East & Africa Opioid Antagonist Sales by Type (2023-2028) & (K Units)
    Table 112. Middle East & Africa Opioid Antagonist Sales by Application (2017-2022) & (K Units)
    Table 113. Middle East & Africa Opioid Antagonist Sales by Application (2023-2028) & (K Units)
    Table 114. Opioid Antagonist Raw Material
    Table 115. Key Manufacturers of Opioid Antagonist Raw Materials
    Table 116. Direct Channel Pros & Cons
    Table 117. Indirect Channel Pros & Cons
    Table 118. Opioid Antagonist Typical Distributors
    Table 119. Opioid Antagonist Typical Customers
List of Figures
    Figure 1. Opioid Antagonist Picture
    Figure 2. Global Opioid Antagonist Revenue Market Share by Type in 2021
    Figure 3. Oral
    Figure 4. Parenteral
    Figure 5. Global Opioid Antagonist Revenue Market Share by Application in 2021
    Figure 6. Hospitals
    Figure 7. Clinics
    Figure 8. Others
    Figure 9. Global Opioid Antagonist Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
    Figure 10. Global Opioid Antagonist Revenue and Forecast (2017-2028) & (USD Million)
    Figure 11. Global Opioid Antagonist Sales (2017-2028) & (K Units)
    Figure 12. Global Opioid Antagonist Price (2017-2028) & (US$/Unit)
    Figure 13. Global Opioid Antagonist Production Capacity (2017-2028) & (K Units)
    Figure 14. Global Opioid Antagonist Production Capacity by Geographic Region: 2022 VS 2028
    Figure 15. Opioid Antagonist Market Drivers
    Figure 16. Opioid Antagonist Market Restraints
    Figure 17. Opioid Antagonist Market Trends
    Figure 18. Global Opioid Antagonist Sales Market Share by Manufacturer in 2021
    Figure 19. Global Opioid Antagonist Revenue Market Share by Manufacturer in 2021
    Figure 20. Opioid Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
    Figure 21. Top 3 Opioid Antagonist Manufacturer (Revenue) Market Share in 2021
    Figure 22. Top 6 Opioid Antagonist Manufacturer (Revenue) Market Share in 2021
    Figure 23. Global Opioid Antagonist Sales Market Share by Region (2017-2028)
    Figure 24. Global Opioid Antagonist Revenue Market Share by Region (2017-2028)
    Figure 25. North America Opioid Antagonist Revenue (2017-2028) & (USD Million)
    Figure 26. Europe Opioid Antagonist Revenue (2017-2028) & (USD Million)
    Figure 27. Asia-Pacific Opioid Antagonist Revenue (2017-2028) & (USD Million)
    Figure 28. South America Opioid Antagonist Revenue (2017-2028) & (USD Million)
    Figure 29. Middle East & Africa Opioid Antagonist Revenue (2017-2028) & (USD Million)
    Figure 30. Global Opioid Antagonist Sales Market Share by Type (2017-2028)
    Figure 31. Global Opioid Antagonist Revenue Market Share by Type (2017-2028)
    Figure 32. Global Opioid Antagonist Price by Type (2017-2028) & (US$/Unit)
    Figure 33. Global Opioid Antagonist Sales Market Share by Application (2017-2028)
    Figure 34. Global Opioid Antagonist Revenue Market Share by Application (2017-2028)
    Figure 35. Global Opioid Antagonist Price by Application (2017-2028) & (US$/Unit)
    Figure 36. North America Opioid Antagonist Sales Market Share by Type (2017-2028)
    Figure 37. North America Opioid Antagonist Sales Market Share by Application (2017-2028)
    Figure 38. North America Opioid Antagonist Sales Market Share by Country (2017-2028)
    Figure 39. North America Opioid Antagonist Revenue Market Share by Country (2017-2028)
    Figure 40. United States Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 41. Canada Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 42. Mexico Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 43. Europe Opioid Antagonist Sales Market Share by Type (2017-2028)
    Figure 44. Europe Opioid Antagonist Sales Market Share by Application (2017-2028)
    Figure 45. Europe Opioid Antagonist Sales Market Share by Country (2017-2028)
    Figure 46. Europe Opioid Antagonist Revenue Market Share by Country (2017-2028)
    Figure 47. Germany Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. France Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. United Kingdom Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 50. Russia Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 51. Italy Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 52. Asia-Pacific Opioid Antagonist Sales Market Share by Region (2017-2028)
    Figure 53. Asia-Pacific Opioid Antagonist Sales Market Share by Application (2017-2028)
    Figure 54. Asia-Pacific Opioid Antagonist Sales Market Share by Region (2017-2028)
    Figure 55. Asia-Pacific Opioid Antagonist Revenue Market Share by Region (2017-2028)
    Figure 56. China Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Japan Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 58. Korea Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 59. India Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Southeast Asia Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Australia Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South America Opioid Antagonist Sales Market Share by Type (2017-2028)
    Figure 63. South America Opioid Antagonist Sales Market Share by Application (2017-2028)
    Figure 64. South America Opioid Antagonist Sales Market Share by Country (2017-2028)
    Figure 65. South America Opioid Antagonist Revenue Market Share by Country (2017-2028)
    Figure 66. Brazil Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. Argentina Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Middle East & Africa Opioid Antagonist Sales Market Share by Type (2017-2028)
    Figure 69. Middle East & Africa Opioid Antagonist Sales Market Share by Application (2017-2028)
    Figure 70. Middle East & Africa Opioid Antagonist Sales Market Share by Region (2017-2028)
    Figure 71. Middle East & Africa Opioid Antagonist Revenue Market Share by Region (2017-2028)
    Figure 72. Turkey Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 73. Egypt Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Saudi Arabia Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. South Africa Opioid Antagonist Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. Manufacturing Cost Structure Analysis of Opioid Antagonist in 2021
    Figure 77. Manufacturing Process Analysis of Opioid Antagonist
    Figure 78. Opioid Antagonist Industrial Chain
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Indivior
Alkermes
Titan Pharmaceuticals
Opiant Pharmaceuticals
Hikma Pharmaceuticals
Orexo
Camurus
Acura Pharmaceuticals
Shionogi
BioDelivery Sciences International
Collegium Pharmaceutical
AstraZeneca

Related Reports

Global Opioid Antagonist Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Opioid Antagonist Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 08 Sep 2021

date Pharma & Healthcare

The Opioid Antagonist market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Opioid Antagonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Opioid Antagonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 30 Aug 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Opioid Antagonist market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global Opioid Antagonist Supply, Demand and Key Producers, 2023-2029

Global Opioid Antagonist Supply, Demand and Key Producers, 2023-2029

date 30 Aug 2023

date Pharma & Healthcare

The global Opioid Antagonist market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Opioid Antagonist Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Opioid Antagonist Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Opioid Antagonist market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Opioid Antagonist Supply, Demand and Key Producers, 2024-2030

Global Opioid Antagonist Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Opioid Antagonist market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>